REPLIGEN CORPORATION - COMMON STOCK
122,32
29-мая-25 13:45:00
15 мин. задержка
Акции
+1,14
+0,94%
Сегодняшний диапазон
120,96 - 123,71
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Repligen Reports Second Quarter 2024 Financial Results
30 июл 2024 04:30:01 Источник Nasdaq GlobeNewswire
-
Repligen Announces Agreement to Acquire Chromatography Innovator Tantti
29 июл 2024 13:00:00 Источник Nasdaq GlobeNewswire
-
Repligen to Report Second Quarter 2024 Financial Results
16 июл 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Announces CEO Transition Plan
13 июн 2024 04:00:00 Источник Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming June Investor Conferences
22 май 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming May Investor Conferences
07 май 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Reports First Quarter 2024 Financial Results
01 май 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen to Report First Quarter 2024 Financial Results
17 апр 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Appoints Maggie A. Pax to Board of Directors
19 мар 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Reports Fourth Quarter and Full Year 2023 Financial Results
21 фев 2024 04:30:01 Источник Nasdaq GlobeNewswire
-
Repligen to Report Fourth Quarter and Full Year 2023 Financial Results
07 фев 2024 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference
19 дек 2023 04:30:00 Источник Nasdaq GlobeNewswire
-
07 дек 2023 04:30:00 Источник Nasdaq GlobeNewswire
-
UPDATE – Repligen Announces Publication of the Company’s 2022 Sustainability Report
14 ноя 2023 11:01:50 Источник Nasdaq GlobeNewswire
-
Repligen Announces Publication of the Company’s 2022 Sustainability Report
14 ноя 2023 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Corporation to Present at Upcoming Investor Conferences
07 ноя 2023 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Launches TangenX® SC as First-to-Market Holder-Free Self-Contained TFF Device
02 ноя 2023 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Reports Third Quarter 2023 Financial Results and Updates Full Year 2023 Financial Guidance
31 окт 2023 04:30:01 Источник Nasdaq GlobeNewswire
-
Repligen to Report Third Quarter 2023 Financial Results
17 окт 2023 04:30:00 Источник Nasdaq GlobeNewswire
-
Repligen Appoints Olivier Loeillot as President and Chief Commercial Officer
02 окт 2023 04:30:00 Источник Nasdaq GlobeNewswire